Biocon Q2 net profit down 53 percent at Rs 68.8 cr supriya kashyap kashyap28 Oct 2017 9:18 AM ISTNew Delhi: Bio-pharmaceutical firm Biocon reported a 53.10 percent dip in its consolidated net profit to ₹68.8 crore for the quarter ended September,...
Biocon aspiring for 1 billion dollar revenues by FY19 Ruby Khatun Khatun11 Sept 2017 10:22 AM ISTNew Delhi: Biocon is betting big on small molecules and generic formulations, biosimilars, branded formulations and research services as it targets $1...
Biocon up 5 per cent as Malaysia arm gets GMP compliance certificate Ruby Khatun Khatun10 Sept 2017 11:19 AM ISTNew Delhi: Shares of biopharmaceutical firm Biocon surged over 5 per cent after the company said its Malaysian arm Biocon Sdn Bhd has received EU GMP...
Biocon gets JDRF support for global study on diabetes molecule Ruby Khatun Khatun7 Sept 2017 10:02 AM ISTNew Delhi: Biotechnology major Biocon on Thursday said it has received financial support from the US-based JDRF for a global clinical study of its...
Biocon, Mylan Present Clinical Data on Insulin Glargine at American Diabetes Associations 77th Scientific Sessions Ruby Khatun Khatun12 Jun 2017 11:29 AM ISTMylan N.V. and Biocon Ltd. announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE studies at the...
